Please ensure Javascript is enabled for purposes of website accessibility

Buy Quality on the Cheap

By Shannon Zimmerman - Updated Nov 11, 2016 at 4:52PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When solid companies are on sale, it's a good time to go shopping.

A quick check of the market's sale rack finds Johnson & Johnson (NYSE:JNJ) trading at an earnings multiple well below its five-year average. Procter & Gamble (NYSE:PG), Cisco (NASDAQ:CSCO), and Novartis (NYSE:NVS) are trading at discounts to their recent historical levels, too. And the likes of AT&T (NYSE:T), Chevron (NYSE:CVX), and Apple (NASDAQ:AAPL) aren't even within shouting distance of their 52-week highs.

Which can mean only one thing, right? It's time to ...

Buy low! Sell high!
Just kidding, actually. I'm sure that's one piece of investment "advice" you've heard all too many times, and the only proper response to it is, "Well, duh." The real question, of course, is how to know whether you're buying low and selling high. Discounted cash flow (DCF) analysis is one compelling way to answer that question.

Show you the money
Rather than focusing myopically on earnings (which are easily fudged) or on some kind of short-term market catalyst (which may never materialize), DCF analysis requires companies to show you the money -- literally.

By zeroing in on a company's free cash flow (cash from operations less capital expenditures), making conservative assumptions about future earnings growth, and applying a discount rate (the return you require given the business's risk), you'll be in a good position to determine whether a company is trading above or below its intrinsic value -- and within your margin of investing safety.

Follow the Fool
Gauging a company's cash flow history relative to its current price and forward-looking prospects is the tack I've taken for the stocks that appear in the Fool's new Ready-Made Millionaire service. One of our selections, for instance, is a medical-equipment manufacturer that delivered more than $840 million of FCF during its last fiscal year. For the 10 years that ended with August, it's cranked out an annualized gain of more than 23%. Another of our companies, a go-go small-cap contender, is a reliable cash-generator. It's racked up an annualized return of more than 24% over that same 10-year period.

Now what?
Coincidence? We think not. Indeed, the next time you think you've found a quality company at a can't-miss price, make sure it shows you the money. And if you'd like to peek at our full Ready-Made lineup when we reopen to new members, click here to learn more about the service and to snag a special report dubbed The 11-Minute Millionaire. The report is completely free, and it'll come in mighty handy, I suspect, as you go about the very important business of generating a little free cash flow of your own.

This article was originally published Jan. 25, 2007. It has been updated.

Shannon Zimmerman runs point on Ready-Made Millionaire and doesn't own shares of any of the companies mentioned. Johnson & Johnson is a Motley Fool Income Investor recommendation. Apple is a Stock Advisor selection. The Fool has a strict disclosure policy.

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Apple Inc. Stock Quote
Apple Inc.
AAPL
$169.24 (2.62%) $4.32
Chevron Corporation Stock Quote
Chevron Corporation
CVX
$155.82 (0.26%) $0.41
Cisco Systems, Inc. Stock Quote
Cisco Systems, Inc.
CSCO
$46.02 (2.45%) $1.10
Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$170.67 (0.29%) $0.49
The Procter & Gamble Company Stock Quote
The Procter & Gamble Company
PG
$146.30 (0.95%) $1.37
Novartis AG Stock Quote
Novartis AG
NVS
$87.43 (0.32%) $0.28

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
373%
 
S&P 500 Returns
122%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/10/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.